BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31043270)

  • 1. Double staining: diagnostic utility in non-small cell lung carcinoma in the era of tissue conservation.
    Hosny Mohammed K; Ewaz A; Cohen C; Siddiqui MT
    J Am Soc Cytopathol; 2017; 6(4):170-175. PubMed ID: 31043270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
    Sethi S; Geng L; Shidham VB; Archuletta P; Bandyophadhyay S; Feng J; Madan S; Shi D; Tranchida P; Giorgadze T
    Cytojournal; 2012; 9():10. PubMed ID: 22582081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
    Gurda GT; Zhang L; Wang Y; Chen L; Geddes S; Cho WC; Askin F; Gabrielson E; Li QK
    Clin Transl Med; 2015; 4():16. PubMed ID: 25977750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A; Schubert PT; Koegelenberg CFN
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p63 and CK5/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis.
    Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Xiong H; Liang Z; Yan W; Chen K
    Thorac Cancer; 2015 May; 6(3):288-95. PubMed ID: 26273374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
    Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
    Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
    Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL
    Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S; Shim H
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
    El Hag M; Schmidt L; Roh M; Michael CW
    Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
    Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT
    Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
    Collins BT; Wang JF; Bernadt CT
    Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.